MEDIVIS is a technology company.
MEDIVIS has raised $25.0M across 3 funding rounds.
MEDIVIS has raised $25.0M in total across 3 funding rounds.
Medivis is a New York City-based medical technology company founded in 2016 by clinicians and engineers, specializing in augmented reality (AR) and artificial intelligence (AI) to advance surgical navigation and precision.[1][2][3] The company builds SurgicalAR, its flagship FDA-cleared platform that transforms 2D medical images like CTs and MRIs into interactive 3D holographic visualizations overlaid directly onto patients, enabling real-time guidance for surgeons in specialties such as spine, cranial, and prostate procedures.[1][3][4][5] It serves enterprise-level hospitals and medical centers—including Lenox Hill, MD Anderson, UPMC, and Swedish Providence—solving the core problem of surgeons relying on flat 2D images that force mental reconstruction and divert attention from patients, thus improving accuracy, reducing operative time, complications, and radiation exposure while enhancing outcomes.[1][3][5][6]
Deployed in over 17 U.S. medical centers with hardware like the Medivis PRO for ORs and portable CORE/VIEWER units, Medivis has achieved key milestones: $2.3M seed funding in 2019, $20M Series A, FDA clearances for SurgicalAR and Spine Navigation, and recognitions like Fast Company's Most Innovative Company of 2024 and TIME's Best Inventions of 2023, signaling strong growth momentum.[1][2][3][4]
Medivis was founded in 2016 in NYC by physicians including CEO Osamah Choudhry, M.D., and President Dr. Christopher Morley, alongside engineers, driven by the frustration of surgeons using outdated 2D imaging that required imaginative mental fusion for precise surgery.[2][3] The idea emerged from clinicians' direct experience in operating rooms, where turning away from patients to interpret scans led to inefficiencies and risks; they leveraged Microsoft HoloLens to pioneer AR overlays for real-time, hands-free 3D visualization.[3]
Early traction came swiftly: In 2019, Medivis launched SurgicalAR at HIMSS, secured $2.3M seed funding led by Initialized Capital, and integrated seamlessly with hospital PACS systems for enterprise adoption.[3] Pivotal moments include FDA clearances for SurgicalAR and Spine Navigation, expansion to over 17 centers, and major awards, evolving from a vision of AR in surgery to a deployed platform revolutionizing medical imaging.[1][2][4]
Medivis rides the wave of spatial computing and AI-driven healthcare transformation, where AR/VR converges with medical imaging to shift from 2D mental reconstruction to immersive 3D reality, amplified by post-pandemic remote surgery demands and AI advancements in computer vision.[2][3][5] Timing is ideal amid FDA's accelerating clearances for AR tools and hospitals seeking reimbursable innovations to cut costs and errors—Medivis' platform aligns with these by enabling immersive training, scalable precision, and reduced radiation, positioning it ahead of navigation systems like robotics.[1][6]
Market forces favor it: Surging adoption of Microsoft HoloLens ecosystems, enterprise PACS integration, and investor interest (e.g., $20M Series A) amid a $50B+ surgical navigation market growing at 10%+ CAGR due to minimally invasive procedures.[1][3] Medivis influences the ecosystem by setting AR as the "standard of care," inspiring collaborators in AI/graphics and driving institutional leadership in outcomes, as seen in partnerships with top centers like Northwell Health.[1][2][5]
Medivis is poised to dominate AR-guided surgery with expansions into more specialties (e.g., "coming soon" 3D tools) and global scaling beyond 17 U.S. centers, fueled by AI enhancements for broader imaging modalities and hardware iterations.[1][4][5] Trends like generative AI for segmentations, hybrid ORs, and value-based care will propel it, potentially capturing share from legacy systems via cost efficiencies and reimbursements.[6]
Its clinician-founded edge ensures sustained innovation, evolving influence from pioneer to ecosystem leader—echoing its mission to make AR the standard, transforming surgical intelligence from vision to ubiquity.[2]
MEDIVIS has raised $25.0M in total across 3 funding rounds.
MEDIVIS's investors include Pareto Holdings, Scalar Capital, Thirty Five Ventures, Thrive Capital, Joi Ito, Stani Kulechov, 2xN, Alumni Ventures, Amasia, Bascom Ventures, Bond, BoxOne Ventures.
MEDIVIS has raised $25.0M across 3 funding rounds. Most recently, it raised $20.0M Series A in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2023 | $20.0M Series A | Pareto Holdings, Scalar Capital, Thirty Five Ventures, Thrive Capital, Joi Ito, Stani Kulechov | |
| Feb 1, 2020 | $3.0M Seed | 2xN, Alumni Ventures, Amasia, Bascom Ventures, Bond, BoxOne Ventures, Builders VC, DecentraNet, Scott Hartley, Flexcap, Flucas Ventures, Incisive Ventures, Lifeforce Capital, Modern Venture Partners, Pareto Holdings, RRE Ventures, SNR, Social Capital, Unpopular Ventures, Claire Diaz-Ortiz, George Godula, Julian Shapiro, Mandeep Singh, Richard Titus | |
| Feb 1, 2019 | $2.0M Seed | 15th Rock Ventures, Arkitekt Ventures, DreamIt Ventures, Fusion Fund, Harmonix Fund, Prime Movers Lab, Rainfall Ventures, Satori Capital, Westcott LLC |